Does omega-3 supplement enhance the therapeutic results of methylphenidate in attention deficit hyperactivity disorder patients?
Behdani F, Hebrani P, Naseraee A, Haghighi MB, Akhavanrezayat A J Res Med Sci 2013 Aug;18(8):653-8 PMID: 24379840 Abstract BACKGROUND: Although most of the ADHD (Attention Deficit Hyperactivity Disorder) patients respond to stimulant drugs very well, alternative drugs are required for non respondents. It has been revealed that subgroups of patients with ADHD have omega-3 […]
Yonkers KA, Blackwell KA, Glover J, Forray A Annu Rev Clin Psychol 2013 Dec; PMID: 24313569 Abstract Women in their reproductive years are at risk of experiencing depressive and anxiety disorders. As such, it is likely that pregnant women will undergo treatment with antidepressants. We review the risk of adverse birth outcomes and neonatal complications […]
A clinical research practice datalink analysis of antidepressant treatment patterns and health care costs in generalized anxiety disorder
Chollet J, Saragoussi D, Clay E, François C Value Health 2013 Dec;16(8):1133-9 PMID: 24326166 Abstract OBJECTIVE: To describe real-life prescription patterns, health care resource use, and costs in adults with generalized anxiety disorder (GAD) initiating antidepressant (AD) treatment in the United Kingdom. METHODS: A retrospective longitudinal cohort study using data from Clinical Research Practice Datalink […]